Clinical Trials Directory

Trials / Completed

CompletedNCT02151838

The Thai Red Cross Society Prevention of Mother-To-Child Transmission of HIV (TRCS PMTCT) Program

The Thai Red Cross AIDS Research Centre

Status
Completed
Phase
Study type
Observational
Enrollment
250 (actual)
Sponsor
Thai Red Cross AIDS Research Centre · Academic / Other
Sex
Female
Age
15 Years – 50 Years
Healthy volunteers
Accepted

Summary

To assess the safety and the efficacy of Highly Active Anti-Retroviral Treatment (HAART) for the Prevention of Mother-To-Child Transmission of HIV (PMTCT)

Detailed description

1. To describe characteristics of HIV-infected pregnant women who request HAART from the Thai Red Cross Society PMTCT (TRCS PMTCT) program 2. To study adverse pregnancy outcomes among HIV-infected pregnant women who receive HAART 3. To study adverse events in infants born to women who receive HAART during pregnancy 4. To evaluate risk factors for HAART-related toxicities and for perinatal HIV transmission 5. To establish the pilot model of care for HIV-infected pregnant women in middle income country

Conditions

Timeline

Start date
2008-09-01
Primary completion
2020-12-01
Completion
2021-07-01
First posted
2014-05-30
Last updated
2021-07-12

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT02151838. Inclusion in this directory is not an endorsement.